Avigen

Avigen is a contract research organisation providing preclinical validation services for cellular immunotherapies using a proprietary microfluidic platform.

The platform measures cellular avidity, the total binding strength between immune and cancer cells, at high throughput using fluid shear stress, enabling identification and isolation of the most potent immune cell candidates from large pools.

Avigen's services support cell therapy developers across multiple modalities including CAR-T, NK cell, and TCR-T therapies.